Ca2+ and pH modulate alternative splicing of exon 5 in NMDA receptor subunit 1

NeuroReport

Volumn 10, Issue 17, 1999, Pages 3659-3664

  Vallano, Mary Lou ^a   Beaman Hall, Carol M ^a   Benmansour, Saloua ^a,b  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Alternative splicing; Calcium; Cerebellum; Granule neurons; NMDA receptor

Indexed keywords

CALCIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; MESSENGER RNA; N METHYLASPARTIC ACID; POLYAMINE; POTASSIUM CHLORIDE;

ALTERNATIVE RNA SPLICING; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL SURVIVAL; CEREBELLUM; EXON; FEMALE; MALE; NERVE GROWTH; NONHUMAN; PH; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; APOPTOSIS; CALCIUM SIGNALING; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT;

ALTERNATIVE SPLICING; ANIMALS; APOPTOSIS; CALCIUM; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CEREBELLUM; EXONS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYDROGEN-ION CONCENTRATION; N-METHYLASPARTATE; NEURONS; POLYAMINES; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER;

EID: 0033607321     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199911260-00036     Document Type: Article

References (19)

1. 1. Vallano ML. Crit Rev Neurobiol 12, 177-204 (1998).
2. 2. Zukin RS and Bennett MVL. Trends Nerurol Sci 18, 306-313 (1995).
3. 3. Traynelis SF and Cull-Candy SG. J Physiol (Lond) 433, 727-763 (1991).
4. 4. Traynelis SF, Hartley M and Heinemann SF. Science 268, 873-876 (1995).
5. 5 Kreutz MR, Bockers TM, Bockmann J et al. J Neurosci 18, 8278-8291 (1998).
6. 6. Nakanishi N, Axel R and Shneider NA. Proc Natl Acad Sci USA 89, 8552-8556 (1992).
7. 7. Della Vedova F, Bonecchi L, Bianchetti A et al. Neuroreport 5, 581-584 (1994).
8. 8. Vallano ML, Lambolez B, Audinat E and Rossier J. J Neurosci 16, 631-639 (1996).
9. 9. Beaman-Hall CM, Leahy JC, Benmansour S and Vallano ML. J Neurochem 75, 1993-2005 (1998).
10. 10. Schramm M, Eimerl S and Costa E. Proc Natl Acad Sci USA 87, 1193-1197 (1990).
11. 11. Grynkiewicz GM, Poenie M and Tsien RY. J Biol Chem 260, 3440-3450 (1985).
12. 12. Balazs R and Hack N. Adv Exp Med Biol 268, 221-228 (1990).
13. 13. McDonough SI, Swartz KJ, Mintz IM et al. J Neurosci 16, 2612-2623 (1996).
14. 14. Oberdorf J, Vallano ML and Wojcikiewicz RJH. J Neurochem 69, 1897-1903 (1997).
15. 15. Williams K. Mol Pharmacol 44, 851-859 (1993).
16. 16. Balazs R, Jorgensen OS and Hack N. Neuroscience 27, 437-451 (1988).
17. 17. Leahy JC, Chen Q and Vallano ML. Neuroscience 63, 457-470 (1994).
18. 18. Zacharias DA and Strehler EE. Curr Biol 6, 1642-1652 (1996).
19. 19. Agell N, Aligue R, Alemany V et al. Cell Calcium 23, 115-121 (1998).